...
首页> 外文期刊>Drug safety: An international journal of medical toxicology and drug experience >Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review
【24h】

Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review

机译:Ivemectin和Doxycline单疗法的安全性和有效性,以及组合在Covid-19治疗中的审查

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction and Objective Ivermectin (IVM) and doxycycline (DOXY) have demonstrated in-vitro activity against SARS-CoV-2, and have a reasonable safety profile. The objective of this systematic review was to explore the evidence in the literature on the safety and efficacy of their use as monotherapy and combination therapy in COVID-19 management.
机译:简介与目的伊维菌素(IVM)和强力霉素(DOXY)已在体外证明具有抗SARS-CoV-2的活性,且具有合理的安全性。2019冠状病毒疾病的系统评价是为了探讨文献中有关单一疗法和联合治疗在COVID-19治疗中的安全性和有效性的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号